DFSCoin (CURRENCY:DFS) traded 6.4% higher against the US dollar during the one day period ending at 9:00 AM Eastern on April 21st. One DFSCoin coin can currently be purchased for about $0.0488 or 0.00000560 BTC on cryptocurrency exchanges including CoinExchange and Cryptopia. In the last seven
The tech-heavy Nasdaq closed higher for a fourth straight session Wednesday, while the Dow industrials finished lower, as stock investors digested hawkish comments from Federal Reserve speakers and a drop in U.S. gasoline inventories bolstered the energy sector.
As the shares of everyone from Kroger Co. (KR) to Foot Locker Inc. (FL) to Blue Apron Holdings Inc. (APRN) get hammered on fears that Amazon.com Inc. (AMZN) s gunning for their business, Netflix Inc. (NFLX) has soared to new highs after delivering yet another earnings report suggesting its business for now remains mostly immune to Amazon’s aggressive incursions.
I like to call it the "perfect income investment." The majority of individual investors have never even heard of this investment, but it's popular with sophisticated investors… the kind that manage billions of dollars. This investment has the safety of a bond. It pays regular income. But it's better than a bond… because it has the upside of stocks. ....More>>>
New York, NY, based Investment company Grandfield & Dodd, Llc buys Enbridge, Johnson Controls International PLC, M&T Bank, Albemarle, Walt Disney Co, Gilead Sciences, US Bancorp, Abbott Laboratories, Vanguard Large-Cap ETF – DNQ, Clorox Co, sells Spectra Energy, St Jude Medical, Nordstrom, Emerson Electric Co, Chubb during the 3-months ended 2017-03-31, according to the most recent....More>>>
Collection House (OTC:CLHSF, ASX:CLH) is a small-cap $133 million revenue Australian stock with little coverage. It is trading cheap at a valuation of 6x EV/EBITDA, with excellent cash flow conversion. The stock has also posted solid and consistent growth, with a fully franked (tax-free) dividend of just under 6%.
Its closest Australian comparable, Credit Corp. Group,....More>>>
With cancer immunotherapies driving an explosion in oncology clinical trials, its becoming increasingly difficult to keep track of key clinical trial activity and potential catalysts. We've analyzed all oncology trials in clinicaltrials.gov and have identified the near term "high impact" trials.
If so, this interest apparently groups us with a shrinking share of Americans if you believe the media. AMC Theatres (NYSE:AMC) lost over 25% of its value recently because so few people are turning up to see the latest movies. And the shares of all the
With hundreds of biotech stocks on the market, who can keep up with them all? Probably no one. What happens as a result is that usually only the biggest biotechs (or the small biotechs getting bought by the biggest biotechs) get a lot of coverage.But sometimes those aren't the stocks to watc